277 related articles for article (PubMed ID: 34952630)
1. CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients.
Cutolo M; Soldano S; Gotelli E; Montagna P; Campitiello R; Paolino S; Pizzorni C; Sulli A; Smith V; Tardito S
Arthritis Res Ther; 2021 Dec; 23(1):306. PubMed ID: 34952630
[TBL] [Abstract][Full Text] [Related]
2. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
3. CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production.
Cutolo M; Soldano S; Montagna P; Sulli A; Seriolo B; Villaggio B; Triolo P; Clerico P; Felli L; Brizzolara R
Arthritis Res Ther; 2009; 11(6):R176. PubMed ID: 19930661
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
[TBL] [Abstract][Full Text] [Related]
5. Abatacept downregulates Fcγ receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis.
Fukue R; Okazaki Y; Gono T; Kuwana M
Arthritis Res Ther; 2022 Aug; 24(1):194. PubMed ID: 35964055
[TBL] [Abstract][Full Text] [Related]
6. The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis.
Cutolo M; Campitiello R; Gotelli E; Soldano S
Front Immunol; 2022; 13():867260. PubMed ID: 35663975
[TBL] [Abstract][Full Text] [Related]
7. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood CD4
Gremese E; Tolusso B; Petricca L; Di Mario C; Gigante MR; Ferraccioli G; Alivernini S
Arthritis Res Ther; 2022 Jun; 24(1):143. PubMed ID: 35706043
[TBL] [Abstract][Full Text] [Related]
9. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
Soldano S; Pizzorni C; Paolino S; Trombetta AC; Montagna P; Brizzolara R; Ruaro B; Sulli A; Cutolo M
PLoS One; 2016; 11(11):e0166433. PubMed ID: 27846260
[TBL] [Abstract][Full Text] [Related]
10. Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay.
Cutolo M; Soldano S; Montagna P; Trombetta AC; Contini P; Ruaro B; Sulli A; Scabini S; Stratta E; Paolino S; Pizzorni C; Smith V; Brizzolara R
Arthritis Res Ther; 2018 Jul; 20(1):157. PubMed ID: 30053831
[TBL] [Abstract][Full Text] [Related]
11. [CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture].
Brizzolara R; Soldano S; Montagna P; Sulli A; Seriolo B; Villaggio B; Triolo PF; Clerico P; Felli L; Molfetta L; Cutolo M
Reumatismo; 2011; 63(2):80-5. PubMed ID: 21776443
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages.
Cutolo M; Paolino S; Pizzorni C; Sulli A; Seriolo B; Cimmino MA; Montagna P; Soldano S; Contini P; Brizzolara R
Clin Exp Rheumatol; 2016; 34(3):500-6. PubMed ID: 26940199
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor α augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression.
Oi K; Tokunaga T; Kuranobu T; Yukawa K; Kohno H; Yoshida Y; Mokuda S; Hirata S; Sugiyama E
Clin Exp Immunol; 2019 Jun; 196(3):392-402. PubMed ID: 30724348
[TBL] [Abstract][Full Text] [Related]
14. Targeting the CD80/CD86 costimulatory pathway with CTLA4-Ig directs microglia toward a repair phenotype and promotes axonal outgrowth.
Louveau A; Nerrière-Daguin V; Vanhove B; Naveilhan P; Neunlist M; Nicot A; Boudin H
Glia; 2015 Dec; 63(12):2298-312. PubMed ID: 26212105
[TBL] [Abstract][Full Text] [Related]
15. Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis.
Ambarus CA; Noordenbos T; de Hair MJ; Tak PP; Baeten DL
Arthritis Res Ther; 2012 Apr; 14(2):R74. PubMed ID: 22494514
[TBL] [Abstract][Full Text] [Related]
16. CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression.
Cutolo M; Montagna P; Soldano S; Contini P; Paolino S; Pizzorni C; Seriolo B; Sulli A; Brizzolara R
Clin Exp Rheumatol; 2015; 33(2):250-4. PubMed ID: 25896473
[TBL] [Abstract][Full Text] [Related]
17. IL-21 impairs pro-inflammatory activity of M1-like macrophages exerting anti-inflammatory effects on rheumatoid arthritis.
Jian L; Li C; Wang X; Sun L; Ma Z; Zhao J
Autoimmunity; 2022 Mar; 55(2):75-85. PubMed ID: 34842006
[No Abstract] [Full Text] [Related]
18. Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte/macrophage surface markers: Relation to the degree of skin involvement.
Mohamed ME; Gamal RM; El-Mokhtar MA; Hassan AT; Abozaid HSM; Ghandour AM; Abdelmoez A Ismail S; A Yousef H; H El-Hakeim E; S Makarem Y; Abdellatif Awad A
Hum Immunol; 2021 Sep; 82(9):634-639. PubMed ID: 34020830
[TBL] [Abstract][Full Text] [Related]
19. Iguratimod promotes transformation of mononuclear macrophages in elderly patients with rheumatoid arthritis by nuclear factor-κB pathway.
Liu S; Song LP; Li RB; Feng LH; Zhu H
World J Clin Cases; 2021 Apr; 9(10):2181-2191. PubMed ID: 33869594
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effect of ASP2408, a novel CD86-selective variant of CTLA4-Ig, in rats and cynomolgus monkeys.
Oshima S; Fujii Y; Karrer EE; Takamura F; Chapin SJ; Neighbors M; Viswanathan S; Devens BH; Higashi Y; Mizuhara H
Int Immunopharmacol; 2016 Nov; 40():310-317. PubMed ID: 27662596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
